Latest Articles

Publication Date
Patients of disgraced gynaecologist to get free health reviews - WAtoday

Patients of disgraced gynaecologist to get free health reviews WAtoday

Published: April 2, 2026, 5:18 a.m.
Patients of disgraced gynaecologist to get free health reviews - smh.com.au

Patients of disgraced gynaecologist to get free health reviews smh.com.au

Published: April 2, 2026, 5:18 a.m.
Patients of disgraced gynaecologist to get free health reviews - The Age

Patients of disgraced gynaecologist to get free health reviews The Age

Published: April 2, 2026, 5:18 a.m.
Adenomyosis Pathophysiology, Diagnostic Advances, and Therapeutic Options.

Adenomyosis is a heterogeneous, nonmalignant uterine disorder characterized by ectopic endometrium within the myometrium, leading to abnormal uterine bleeding, dysmenorrhea, chronic pelvic pain, and subfertility. Once considered a disease of …

Published: April 2, 2026, midnight
Thoracic endometriosis in an inoperable patient.

In this case report, we present a case of a woman in her 30s who was diagnosed with thoracic endometriosis presenting as a large pulmonary mass. Hormonal treatment progestin (synthetic …

Published: April 2, 2026, midnight
Support for former patients of Simon Gordon - Australian Government Department of Health, Disability and Ageing

Support for former patients of Simon Gordon Australian Government Department of Health, Disability and Ageing

Published: April 1, 2026, 9:31 p.m.
Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment - Femtech Insider

Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment Femtech Insider

Published: April 1, 2026, 11:54 a.m.
Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment - femtechinsider.com

Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment femtechinsider.com

Published: April 1, 2026, 11:54 a.m.
Stereoselectivity and functional plasticity of a common ligand-binding pocket in TRPM3.

The transient receptor potential melastatin 3 (TRPM3) channel is a key mediator of peripheral pain signaling, and pathogenic mutations in TRPM3 are linked to neurodevelopmental delay and epilepsy. Despite the …

Published: April 1, 2026, midnight
Endometriosis patient after years-long battle for diagnosis: Trust your symptoms - DiscoverWestman

Endometriosis patient after years-long battle for diagnosis: Trust your symptoms DiscoverWestman

Published: March 31, 2026, 10:43 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!